This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 08/08/2023
Location: Virtual
Subject: Oncologic Drug Shortages
FDA Participant/Group: ANDREW ZACHER; JULIA TIERNEY;
Non FDA Participant/Group: Leslie Busby (Rocky Mountain Cancer Center);

Event Date: 08/10/2023
Location: Virtual
Subject: Oncologic Drug Shortages
FDA Participant/Group: HILARY MARSTON; ANDREW ZACHER;
Non FDA Participant/Group: Government and several National Cancer Institute Designated Cancer Centers

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Carol Cave, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

Event Date: 08/10/2023
Location: Silver Spring, MD
Subject: FDA Annual Student Scientific Research Day 2023; Keynote Remarks
FDA Participant/Group: N/A
Non FDA Participant/Group: Staff, students, and stakeholders

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 08/10/2023
Location: Washington, DC
Subject: National Science Foundation Cellular Biomanufacturing 2023 Workshop; Panelist: Complex Regulatory Landscape Surrounding the Translation of Cellular Biomanufacturing
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, regulatory, and academic stakeholders

Event Date: 08/10/2023
Location: Washington, DC
Subject: National Science Foundation Cellular Biomanufacturing 2023 Workshop; Keynote Presentation: Regulatory Considerations for Cellular Biomanufacturing
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, regulatory, and academic stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 08/08/2023
Location: Virtual
Subject: Continuing Concerns with the FY 2019-2023 Frozen Berry Sampling Assignment and Analytical Method, Retailer(s) Adoption of Enteric Viruses
FDA Participant/Group: KRISTINE BUTLER; TIMOTHY JACKSON; DOUGLAS STEARN; KARI BARRETT; DOUGLAS TICKER;
Non FDA Participant/Group: Donna Garren, Sanjay Gummalla (American Frozen Food Institution); Elizabeth Fawell (Hogan, Lovells, LLP); Lee-Ann Jaykus (North Carolina State University);

Event Date: 08/11/2023
Location: Virtual
Subject: Standards of Identity for Yogurt
FDA Participant/Group: ELIZABETH BRICZINSKI; NICHOLAS ALEXANDER;
Non FDA Participant/Group: Jennifer Trodden (New York State Department of Agriculture);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 08/11/2023
Location: Virtual
Subject: Update on Truth Initiative’s Activities
FDA Participant/Group: N/A
Non FDA Participant/Group: Robin Koval (Truth Initiative);

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event